Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WiseGo Renal Denervation for Resistant Hypertension
NCT02900729Phase 3Unknown
- Sponsor
- WiseGain
- Start
- Oct 2016
- Primary completion
- Aug 2017
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in resistant hypertension (RH) (2 arms), sponsored by WiseGain. Primary endpoint: Change in average 24-hour systolic blood pressure by ambulatory blood pressure monitoring at 3 months. Status: unknown.
02
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT02900729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02900729.